+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

AI Opportunities in Personalised Medicine - Product Thumbnail Image

AI Opportunities in Personalised Medicine

  • Report
  • March 2023
  • Global
From
From
From
Biopharmaceuticals Market Report and Forecast 2023-2031 - Product Thumbnail Image

Biopharmaceuticals Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
From
From
Loading Indicator